Ariosa, Inc., a prominent player in the biotechnology sector, is headquartered in the United States and operates extensively across North America and Europe. Founded in 2008, the company has made significant strides in the field of non-invasive prenatal testing (NIPT), establishing itself as a leader in genetic screening solutions. Ariosa's flagship product, the Harmony Prenatal Test, is renowned for its accuracy and reliability, offering expectant parents peace of mind through advanced genomic technology. The test's unique approach to detecting chromosomal abnormalities sets it apart in a competitive market, contributing to Ariosa's strong reputation among healthcare professionals. With a commitment to innovation and quality, Ariosa, Inc. has achieved notable milestones, including partnerships with leading healthcare providers and recognition for its contributions to prenatal care. The company continues to shape the future of genetic testing, ensuring that families receive the best possible information during pregnancy.
We don't have data for Ariosa, Inc, but we can show you information about their parent organization instead.
View parent company